Form 4 for CLNN Clene Inc.
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0001562180-22-004174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | 2022-05-16 | CLNN | Glanzman Robert | Chief Medical Off | S - Sale | $2.03 | -4,717 | 10.6K | -31% | -$9,576 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | S | D | 4,717 | $2.03 | 10,564 | D | — | — | (F1) The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman. |